Skip to main content

Table 2 Recent studies on isolation rates of NTM from human clinical specimens in different settings

From: Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014

Setting Years Prevalent NTM species % of total isolates Trend Reference
Tuscany (Italy) 2004–2014 M. avium 41.5 Increase This study
M. intracellulare 14.3
M. gordonae 11.6
England, Wales and Northern Ireland 1995–2006 M. avium-intracellulare 42.9 Increase 9
M. malmoense 13.7
M. kansasii 12.5
Scotland 2000–2010 M. avium complex 48.1 No clear trend 13
M. malmoense 17.7
M. abscessus 9.8
The Netherlands 2000–2006 M. avium complex 39.0 Increase 14
M. gordonae 14.1
M. kansasii 7.4
Croatia 2006–2010 M. gordonae 42.9 Increase 11
M. xenopi 15.5
M. fortuitum 11.5
Athens (Greece) 2007–2013 M. gordonae 13.9 No trend 20
M. avium 13.1
M. fortuitum 12.2
Virginia (USA) 2001–2009 M. avium complex 40.9 Increase 22
M. gordonae 28.7
M. abscessus 4.5
Oregon (USA) 2007–2012 M. avium-intracellulare 86 Increase 21
M. chelonae/abscessus 6
Shangai (China) 2008–2012 M. kansasii 45.0 Increase 23
M. intracellulare 20.8
M. chelonae/abscessus 14.9
Cheonan (Korea) 2005–2011 M. intracellulare 51.3 Increase 24
M. avium 14.7
M. kansasii 7.8
South Korea 2001–2011 M. avium complex 53 Increase 25
M. abscessus-massiliense 25
M. fortuitum 6